{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:58:23Z","timestamp":1787065103629,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010960"],"award-info":[{"award-number":["2021A1515010960"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515011066"],"award-info":[{"award-number":["2022A1515011066"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202002030225"],"award-info":[{"award-number":["202002030225"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202102021281"],"award-info":[{"award-number":["202102021281"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["210909154531306"],"award-info":[{"award-number":["210909154531306"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31901696"],"award-info":[{"award-number":["31901696"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803393"],"award-info":[{"award-number":["81803393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.biopha.2022.113303","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:56:53Z","timestamp":1655794613000},"page":"113303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1"],"prefix":"10.1016","volume":"153","author":[{"given":"Tianqiao","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuancao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113303_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","article-title":"Uric acid, hyperuricemia and vascular diseases","volume":"17","author":"Jin","year":"2012","journal-title":"Front. Biosci. -Landmark"},{"key":"10.1016\/j.biopha.2022.113303_bib2","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1038\/s41598-018-22570-9","article-title":"Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China","volume":"8","author":"Song","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113303_bib3","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113303_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s42255-021-00454-z","article-title":"Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation","volume":"3","author":"Andres-Hernando","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2022.113303_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf9044","article-title":"A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice","volume":"9","author":"Chiaro","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2022.113303_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","article-title":"Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase","volume":"169","author":"Cantor","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.113303_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41431-021-00830-z","article-title":"Genetic correlations between traits associated with hyperuricemia, gout, and comorbidities","volume":"29","author":"Reynolds","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2022.113303_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/BOR.0000000000000154","article-title":"Evolution of management of gout: a comparison of recent guidelines","volume":"27","author":"Khanna","year":"2015","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.biopha.2022.113303_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2022.113303_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semarthrit.2012.03.013","article-title":"Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review","volume":"42","author":"Curiel","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113303_bib11","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2022.113303_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1592\/phco.30.6.594","article-title":"Urate-lowering therapy for gout: focus on febuxostat","volume":"30","author":"Love","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biopha.2022.113303_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00296-014-3189-6","article-title":"Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis","volume":"35","author":"Castrejon","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.biopha.2022.113303_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.semarthrit.2016.07.015","article-title":"Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution","volume":"46","author":"Stamp","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113303_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjms.2018.11.018","article-title":"Allopurinol-induced Stevens-Johnson syndrome","volume":"357","author":"Gupta","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.biopha.2022.113303_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity.\u00a0Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am. J. Med"},{"key":"10.1016\/j.biopha.2022.113303_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117272","article-title":"Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-\u03b1) expression","volume":"243","author":"Abdel-Razek","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.113303_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41467-021-27945-7","article-title":"Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia","volume":"13","author":"Sands","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113303_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2022.132100","article-title":"In vitro inhibitory effects of polyphenols from Tartary buckwheat on xanthine oxidase: identification, inhibitory activity, and action mechanism","volume":"379","author":"Li","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2022.113303_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.apsb.2017.05.004","article-title":"Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice","volume":"8","author":"Qin","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113303_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1134\/S1070428014120252","article-title":"Esterification of 2,4-dihydroxybenzoic acid","volume":"50","author":"Derkach","year":"2014","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.biopha.2022.113303_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejmech.2016.05.033","article-title":"Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors","volume":"121","author":"Liang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.biopha.2022.113303_bib23","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1021\/ci300601q","article-title":"Enhancing molecular shape comparison by weighted Gaussian functions","volume":"53","author":"Yan","year":"2013","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.biopha.2022.113303_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/15257770802146577","article-title":"Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol","volume":"27","author":"Okamoto","year":"2008","journal-title":"Nucl. Nucleotides Nucleic"},{"key":"10.1016\/j.biopha.2022.113303_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2015.05.005","article-title":"An open-label, 6-month study of allopurinol safety in gout: The LASSO study","volume":"45","author":"Becker","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113303_bib26","first-page":"Cd010457","article-title":"Uricosuric medications for chronic gout, Cochrane Db.","volume":"11","author":"Kydd","year":"2014","journal-title":"Syst. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2022.113303_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.apsb.2019.10.007","article-title":"Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia","volume":"10","author":"Pan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2022.113303_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jep.2016.10.001","article-title":"Actions of water extract from cordyceps militaris in hyperuricemic mice induced by potassium oxonate combined with hypoxanthine","volume":"194","author":"Yong","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2022.113303_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/13880209.2021.1885450","article-title":"Hypouricaemic and nephroprotective effects of Poria cocos in hyperuricemic mice by up-regulating ATP-binding cassette super-family G member 2","volume":"59","author":"Liang","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2022.113303_bib30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3389\/fphar.2017.00996","article-title":"Hypouricemic effects of ganoderma applanatum in Hyperuricemia Mice through OAT1 and GLUT9","volume":"8","author":"Yong","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113303_bib31","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1248\/cpb.30.1496","article-title":"Isoflavonoids and the other constituents in callus tissues of Pueraria lobata","volume":"30","author":"Takeya","year":"1982","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.biopha.2022.113303_bib32","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.bcp.2013.08.011","article-title":"3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout","volume":"86","author":"L\u00fc","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113303_bib33","doi-asserted-by":"crossref","first-page":"i42","DOI":"10.1093\/rheumatology\/kex433","article-title":"Novel uricosurics","volume":"57","author":"Bardin","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.biopha.2022.113303_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7861\/clinmedicine.17-1-54","article-title":"Gout - a guide for the general and acute physicians","volume":"17","author":"Abhishek","year":"2017","journal-title":"Clin. Med."},{"key":"10.1016\/j.biopha.2022.113303_bib35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.2009.159","article-title":"Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury","volume":"76","author":"Bouchard","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.113303_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13543784.2018.1471133","article-title":"Investigational drugs for hyperuricemia, an update on recent developments","volume":"27","author":"Pascart","year":"2018","journal-title":"Expert Opin. Investig. Drug"},{"key":"10.1016\/j.biopha.2022.113303_bib37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semarthrit.2018.06.004","article-title":"Combination urate-lowering therapy in the treatment of gout: What is the evidence?","volume":"48","author":"Perez-Ruiz","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2022.113303_bib38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2016-209213","article-title":"Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)","volume":"76","author":"Bardin","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2022.113303_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/bj3060225","article-title":"Tissue- and cell-specific expression of mouse xanthine oxidoreductase gene in vivo: regulation by bacterial lipopolysaccharide","volume":"306","author":"Kurosaki","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2022.113303_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jb\/mvm053","article-title":"Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate","volume":"141","author":"Yamaguchi","year":"2007","journal-title":"J. Biochem."},{"key":"10.1016\/j.biopha.2022.113303_bib41","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/ijms19051394","article-title":"Hypouricemic effect of 2,5-Dihydroxyacetophenone, a computational screened bioactive compound from ganoderma applanatum, on hyperuricemic mice","volume":"19","author":"Liang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.113303_bib42","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-020-16525-w","article-title":"The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion","volume":"11","author":"Hoque","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113303_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.biopha.2022.113303_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050197","article-title":"SLC2A9 is a high-capacity urate transporter in humans","volume":"5","author":"Caulfield","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2022.113303_bib45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.biopha.2022.113303_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41401-021-00640-5","article-title":"CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia","volume":"43","author":"Zhao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.113303_bib47","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/ml500343r","article-title":"Identification of 8-aminoadenosine derivatives as a new class of human concentrative nucleoside transporter 2 inhibitors","volume":"6","author":"Tatani","year":"2015","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222006928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:48:50Z","timestamp":1779968930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222006928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"alternative-id":["S0753332222006928"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113303","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113303"}}